KIRSTEN SOBKOWICH: Open Payments
NPI 1891431771 · GROTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 29 payments from 14 companies in 2025. Trend: 2023 $953 · 2024 $1,528 · 2025 $760
Food & beverage: $760
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 6 | $196 |
| Janssen Biotech, Inc. | 4 | $152 |
| Amgen Inc. | 8 | $145 |
| PFIZER INC. | 1 | $34 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Fresenius Kabi USA, LLC | 1 | $26 |
| Novo Nordisk Inc | 1 | $25 |
| ABBVIE INC. | 1 | $23 |
| Medtronic, Inc. | 1 | $23 |
Products named: Bimzelx, TREMFYA, ENBREL, XELJANZ, NEFFY, ORENCIA, EVENITY, Tyenne.
Industry payments across MA — which companies pay providers there.
